Synthesis, molecular modeling, and K+ channel-blocking activity of dequalinium analogues having semirigid linkers

被引:24
|
作者
Rosa, JC
Galanakis, D
Ganellin, CR
Dunn, PM
机构
[1] UNIV LONDON UNIV COLL,DEPT CHEM,LONDON WC1E 6BT,ENGLAND
[2] UNIV LONDON UNIV COLL,DEPT PHARMACOL,LONDON WC1E 6BT,ENGLAND
关键词
D O I
10.1021/jm950884a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dequalinium [1,1'-(decane-1,10-diyl)bis(2-methyl-4-aminoquinolinium)] is an effective blocker of the small conductance Ca2+-activated K+ channel. It has been shown that the number of methylene groups in the alkyl chain linking the two quinolinium rings of this type of molecule is not critical for activity. To further investigate the role of the linker, analogues of dequalinium have been synthesized, in which the alkyl chain has been replaced by CH(2)XCH(2) where X is a rigid or semirigid group containing aromatic rings. The compounds have been tested for blockade of the slow after-hyperpolarization on rat sympathetic neurons. The most potent compounds have X = phenanthryl, fluorenyl, cis-stilbene, and C6H4(CH2)(n)C6H4, where n = 0-4. The conformational preferences of the compounds were investigated using the XED/COSMIC molecular modeling system. Although there is some dependence of the potency of the analogue on the conformational properties of the linker (X), overall, X groups having substantial structural differences are tolerated. It seems that X provides a support for the two quinolinium groups and does not interact with the channel directly. The intramolecular separation between the quinolinium rings, which is provided by rigid groups X, is not critical for activity; this may be attributed to the residual conformational mobility of the heterocycles and to the extensive delocalization of the positive charge. These two factors may permit favorable contacts between the quinolinium groups and the channel over a range of intramolecular separations.
引用
收藏
页码:4247 / 4254
页数:8
相关论文
共 50 条
  • [1] THE CHARYBDOTOXIN FAMILY OF K+ CHANNEL-BLOCKING PEPTIDES
    MILLER, C
    NEURON, 1995, 15 (01) : 5 - 10
  • [2] β-cell toxicity of ATP-sensitive K+ channel-blocking insulin secretagogues
    Rustenbeck, I
    Krautheim, A
    Jörns, A
    Steinfelder, HJ
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (09) : 1733 - 1741
  • [3] MOLECULAR MODELING OF A CHANNEL-BLOCKING PEPTIDE FROM TRIMERESURUS-WAGLERI
    HYVONEN, M
    MATTILA, K
    RANTALA, TT
    SELLIN, LC
    BIOPHYSICAL JOURNAL, 1994, 66 (02) : A63 - A63
  • [4] A K+ channel-blocking peptide from venom of Chinese scorpion Buthus martensii Karsch
    Wu, G
    Wei, DS
    He, FH
    Hu, GY
    Wu, HM
    ACTA PHARMACOLOGICA SINICA, 1998, 19 (04): : 317 - 321
  • [5] Synthesis and expression of the gene coding for noxiustoxin, a K+ channel-blocking peptide from the venom of the scorpion Centruroides noxius
    Martinez, F
    Becerril, B
    Gurrola, GB
    Martin, BM
    Possani, LD
    TOXICON, 1996, 34 (11-12) : 1413 - 1419
  • [6] K+ CHANNEL-BLOCKING AGENTS MAY AUGMENT SYMPATHETIC TRANSMITTER SECRETION BY ACTION UPSTREAM OF VARICOSITIES
    STJARNE, L
    MSGHINA, M
    STJARNE, E
    ACTA PHYSIOLOGICA SCANDINAVICA, 1989, 137 (01): : 151 - 152
  • [7] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF DEQUALINIUM ANALOGS AS K+ CHANNEL BLOCKERS - INVESTIGATIONS ON THE ROLE OF THE CHARGED HETEROCYCLE
    GALANAKIS, D
    DAVIS, CA
    HERRERO, BD
    GANELLIN, CR
    DUNN, PM
    JENKINSON, DH
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (04) : 595 - 606
  • [8] Martentoxin, a novel K+ channel-blocking peptide:: purification, cDNA and genomic cloning, and electrophysiological and pharmacological characterization
    Ji, YH
    Wang, WX
    Ye, JG
    He, LL
    Li, YJ
    Yan, YP
    Zhou, Z
    JOURNAL OF NEUROCHEMISTRY, 2003, 84 (02) : 325 - 335
  • [9] Induction of seizures by the potent K+ channel-blocking scorpion venom peptide toxins tityustoxin-Kα and pandinustoxin-Kα
    Juhng, KN
    Kokate, TG
    Yamaguchi, S
    Kim, BY
    Rogowski, RS
    Blaustein, MP
    Rogawski, MA
    EPILEPSY RESEARCH, 1999, 34 (2-3) : 177 - 186
  • [10] THE INHIBITORY EFFECTS OF K+ CHANNEL-BLOCKING AGENTS ON LYMPHOCYTE-T PROLIFERATION AND LYMPHOKINE PRODUCTION ARE NONSPECIFIC
    SCHELL, SR
    NELSON, DJ
    FOZZARD, HA
    FITCH, FW
    JOURNAL OF IMMUNOLOGY, 1987, 139 (10): : 3224 - 3230